POSB132 Ferric Carboxymaltose for the Treatment of Iron Deficiency in Patients with Acute Heart Failure with Reduced Ejection Fraction: Events Avoided and Cost Savings from the Perspective of Healthcare Payers in the United States
Abstract
Authors
P McEwan P Ponikowski G Rosano AJS Coats F Dorigotti D O'Sullivan A Ramirez de Arellano Serna EA Jankowska